Artificial Intelligence and Intellectual Property Law - Position Statement of the Max Planck Institute for Innovation and Competition of 9 April 2021 on the Current Debate
Josef Drexl(Max Planck Institute for Innovation and Competition), Klaus Wiedemann(Universität Hamburg), Begoña González Otero(Max Planck Institute for Innovation and Competition), Luc Desaunettes-Barbero(UCLouvain), Reto M. Hilty(Max Planck Institute for Innovation and Competition), Peter R. Slowinski(Max Planck Institute for Innovation and Competition), Jure Globočnik(Max Planck Institute for Innovation and Competition), Stefan Scheuerer(Max Planck Institute for Innovation and Competition), Jörg Hoffmann(Max Planck Institute for Innovation and Competition), Heiko Richter(Max Planck Institute for Innovation and Competition), Shraddha Kulhari(Max Planck Institute for Innovation and Competition), Daria Kim(Max Planck Institute for Innovation and Competition)
Cited by 21
Related Papers
Factor H autoantibodies in atypical hemolytic uremic syndrome correlate with CFHR1/CFHR3 deficiency
|Blood|2007|356
Deletion of Complement Factor H–Related Genes CFHR1 and CFHR3 Is Associated with Atypical Hemolytic Uremic Syndrome
|PLoS Genetics|2007|325
Factor H and Atypical Hemolytic Uremic Syndrome
|Journal of the American Society of Nephrology|2005|123
The Data Sharing Economy: On the Emergence of New Intermediaries
|GRURRR. Gewerblicher Rechtsschutz und Urheberrecht, Rechtsprechungs-Report/GRUR-DVD/GRUR-CD/IIC/Gewerblicher Rechtsschutz und Urheberrecht/Gewerblicher Rechtsschutz und Urheberrecht. Internationaler Teil|2018|101
Functional analyses indicate a pathogenic role of factor H autoantibodies in atypical haemolytic uraemic syndrome
|Nephrology Dialysis Transplantation|2009|78